Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 31

1.

Pharmacotherapy of Acute Bipolar Depression in Adults: An Evidence Based Approach.

Muneer A.

Korean J Fam Med. 2016 May;37(3):137-48. doi: 10.4082/kjfm.2016.37.3.137. Epub 2016 May 26. Review.

2.

Second-Generation Antipsychotics During the Lactation Period: A Comparative Systematic Review on Infant Safety.

Uguz F.

J Clin Psychopharmacol. 2016 Jun;36(3):244-52. doi: 10.1097/JCP.0000000000000491.

PMID:
27028982
3.

Atypical Antipsychotics in the Treatment of Acute Bipolar Depression with Mixed Features: A Systematic Review and Exploratory Meta-Analysis of Placebo-Controlled Clinical Trials.

Fornaro M, Stubbs B, De Berardis D, Perna G, Valchera A, Veronese N, Solmi M, Ganança L.

Int J Mol Sci. 2016 Feb 16;17(2):241. doi: 10.3390/ijms17020241.

4.

Assessing drug-drug interactions through therapeutic drug monitoring when administering oral second-generation antipsychotics.

Spina E, Hiemke C, de Leon J.

Expert Opin Drug Metab Toxicol. 2016 Apr;12(4):407-22. doi: 10.1517/17425255.2016.1154043. Epub 2016 Feb 29.

PMID:
26878495
5.
6.

Lurasidone for the treatment of bipolar depression: an evidence-based review.

Franklin R, Zorowitz S, Corse AK, Widge AS, Deckersbach T.

Neuropsychiatr Dis Treat. 2015 Aug 19;11:2143-52. doi: 10.2147/NDT.S50961. eCollection 2015. Review.

7.

Lurasidone in the treatment of schizophrenia: a critical evaluation.

Bruijnzeel D, Yazdanpanah M, Suryadevara U, Tandon R.

Expert Opin Pharmacother. 2015;16(10):1559-65. doi: 10.1517/14656566.2015.1058780. Review.

PMID:
26111577
8.

Systematic Literature Review of the Methods Used to Compare Newer Second-Generation Agents for the Management of Schizophrenia: A focus on Health Technology Assessment.

Kruse G, Wong BJ, Duh MS, Lefebvre P, Lafeuille MH, Fastenau JM.

Pharmacoeconomics. 2015 Oct;33(10):1049-67. doi: 10.1007/s40273-015-0285-8.

PMID:
25963579
9.

Hyperprolactinemia and medications for bipolar disorder: systematic review of a neglected issue in clinical practice.

Pacchiarotti I, Murru A, Kotzalidis GD, Bonnin CM, Mazzarini L, Colom F, Vieta E.

Eur Neuropsychopharmacol. 2015 Aug;25(8):1045-59. doi: 10.1016/j.euroneuro.2015.04.007. Epub 2015 Apr 14. Review.

PMID:
25937241
10.

Antipsychotic switching in schizoaffective disorder: A systematic review.

Murru A, Hidalgo D, Bernardo M, Bobes J, Saiz-Ruiz J, Álamo C, Vieta E.

World J Biol Psychiatry. 2015 Mar 9:1-19. [Epub ahead of print]

PMID:
25751661
11.

The pharmacodynamic properties of lurasidone and their role in its antidepressant efficacy in bipolar disorder.

Fountoulakis KN, Gazouli M, Kelsoe J, Akiskal H.

Eur Neuropsychopharmacol. 2015 Mar;25(3):335-42. doi: 10.1016/j.euroneuro.2014.11.010. Epub 2014 Nov 29. Review.

PMID:
25596883
12.

Current landscape, unmet needs, and future directions for treatment of bipolar depression.

Frye MA, Prieto ML, Bobo WV, Kung S, Veldic M, Alarcon RD, Moore KM, Choi DS, Biernacka JM, Tye SJ.

J Affect Disord. 2014 Dec;169 Suppl 1:S17-23. doi: 10.1016/S0165-0327(14)70005-9. Review.

13.

Weight gain and antipsychotics: a drug safety review.

Musil R, Obermeier M, Russ P, Hamerle M.

Expert Opin Drug Saf. 2015 Jan;14(1):73-96. doi: 10.1517/14740338.2015.974549. Epub 2014 Nov 15. Review.

PMID:
25400109
14.

Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis.

Taylor DM, Cornelius V, Smith L, Young AH.

Acta Psychiatr Scand. 2014 Dec;130(6):452-69. doi: 10.1111/acps.12343. Epub 2014 Oct 6. Review.

PMID:
25283309
15.

Efficacy of lurasidone across five symptom dimensions of schizophrenia: pooled analysis of short-term, placebo-controlled studies.

Loebel A, Cucchiaro J, Silva R, Mao Y, Xu J, Pikalov A, Marder SR.

Eur Psychiatry. 2015 Jan;30(1):26-31. doi: 10.1016/j.eurpsy.2014.08.001. Epub 2014 Oct 3.

PMID:
25280429
16.

The quality of reporting of phase II and III trials for new antipsychotics: a systematic review.

Patel MX, Collins S, Hellier J, Bhatia G, Murray RM.

Psychol Med. 2015 Feb;45(3):467-79. doi: 10.1017/S0033291714001214. Epub 2014 Jun 2. Review.

PMID:
25065545
17.

Treatments for acute bipolar depression: meta-analyses of placebo-controlled, monotherapy trials of anticonvulsants, lithium and antipsychotics.

Selle V, Schalkwijk S, Vázquez GH, Baldessarini RJ.

Pharmacopsychiatry. 2014 Mar;47(2):43-52. doi: 10.1055/s-0033-1363258. Epub 2014 Feb 18. Review.

PMID:
24549862
18.

Dose equivalents for second-generation antipsychotics: the minimum effective dose method.

Leucht S, Samara M, Heres S, Patel MX, Woods SW, Davis JM.

Schizophr Bull. 2014 Mar;40(2):314-26. doi: 10.1093/schbul/sbu001. Epub 2014 Feb 3.

19.

Asenapine, blonanserin, iloperidone, lurasidone, and sertindole: distinctive clinical characteristics of 5 novel atypical antipsychotics.

Wang SM, Han C, Lee SJ, Patkar AA, Masand PS, Pae CU.

Clin Neuropharmacol. 2013 Nov-Dec;36(6):223-38. doi: 10.1097/WNF.0b013e3182aa38c4. Review.

PMID:
24201235
20.
Items per page

Supplemental Content

Loading ...
Write to the Help Desk